Skip to main content
. Author manuscript; available in PMC: 2015 Feb 1.
Published in final edited form as: Lipids. 2013 Oct 5;49(2):119–131. doi: 10.1007/s11745-013-3843-x

Fig. 3.

Fig. 3

Nε-lysine acetylation in peroxisome fractions parallels the induction (proliferation) of peroxisomes in the liver of PPARα-agonist treated animals. Equal amounts (50 µg) of peroxisomal pool fractions proteins isolated from livers of untreated (UT) and ciprofibrate-treated (CIP) animals at different treatment intervals (1, 2, 4, 6, 9, 11, 14 days) were resolved by SDS-electrophoresis, transferred to nitrocellulose and analyzed by western blot using anti-Nε-acetyl-lysine antibody (a) and antibodies against the PPARα-agonist inducible peroxisomal enzyme Acyl-CoA oxidase-l (ACOX-1; 50 kDa subunit) (b), as described in the “Materials and Methods” . Western blots are representative of at least two individual analyses